Sara Laurencin

Dr. Sara Laurencin

Université Paul Sabatier Toulouse 3
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2007 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
PKPhilippe Kémoun
Philippe Kémoun
SLSara Laurencin
Sara Laurencin
JRJacqueline Rue
Jacqueline Rue
JFJean-Christophe Farges
Jean-Christophe Farges
IGIsabelle Gennero
Isabelle Gennero
JSJean-Pierre Salles
Jean-Pierre Salles

1 January 2018 in Therapeutic Advances in Medical Oncology
Verified
Journal Article
Open access
PDF file
ADAntoine Dubuc
Antoine Dubuc
PMPaul Monsarrat
Paul Monsarrat
FVFrançois Virard
François Virard
NMNofel Merbahi
Nofel Merbahi
JSJean-Philippe Sarrette
Jean-Philippe Sarrette
SCSarah Cousty
Sarah Cousty
Cold-atmospheric plasma (CAP) is an ionized gas produced at an atmospheric pressure. The aim of this systematic review is to map the use of CAP in oncology and the implemented methodologies (cell targets, physical parameters, direct or indirect therapies). PubMed, the International Clinical Trials Registry Platform and Google Scholar were explored until 31 December 2017 for studies regarding the use of plasma treatment in oncology (in vitro, in vivo, clinical trials). 190 original articles were included. Plasma jets are the most-used production systems (72.1%). Helium alone was the most-used gas (35.8%), followed by air (26.3%) and argon (22.1%). Studies were mostly in vitro (94.7%) and concerned direct plasma treatments (84.2%). The most targeted cancer cell lines are human cell lines (87.4%), in particular, in brain cancer (16.3%). This study highlights the multiplicity of means of production and clinical applications of the CAP in oncology. While some devices may be used directly at the bedside, others open the way for the development of new pharmaceutical products that could be generated at an industrial scale. However, its clinical use strongly needs the development of standardized reliable protocols, to determine the more efficient type of plasma for each type of cancer, and its combination with conventional treatments.

30 July 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
CTCharlotte Thomas
Charlotte Thomas
MMMatthieu Minty
Matthieu Minty
AVAlexia VINEL
Alexia VINEL
Thibault CanceillThibault Canceill
Thibault Canceill
PLPascale Loubières
Pascale Loubières
SLSara Laurencin
Sara Laurencin
The oral cavity is host to a complex and diverse microbiota community which plays an important role in health and disease. Major oral infections, i.e., caries and periodontal diseases, are both responsible for and induced by oral microbiota dysbiosis. This dysbiosis is known to have an impact on other chronic systemic diseases, whether triggering or aggravating them, making the oral microbiota a novel target in diagnosing, following, and treating systemic diseases. In this review, we summarize the major roles that oral microbiota can play in systemic disease development and aggravation and also how novel tools can help investigate this complex ecosystem. Finally, we describe new therapeutic approaches based on oral bacterial recolonization or host modulation therapies. Collaboration in diagnosis and treatment between oral specialists and general health specialists is of key importance in bridging oral and systemic health and disease and improving patients’ wellbeing.

1 September 2011 in Bone
Verified
Journal Article
Closed access
IGIsabelle Gennero
Isabelle Gennero
SLSara Laurencin
Sara Laurencin
FCFrançoise Conte-Auriol
Françoise Conte-Auriol
FBFabienne Briand-Mesange
Fabienne Briand-Mesange
DLDanielle Laurencin
Danielle Laurencin
Jean Pierre SallesJean Pierre Salles
Jean Pierre Salles

1 August 2007 in Tissue and Cell
Verified
Journal Article
Closed access
PKP. Kémoun
P. Kémoun
SLSara Laurencin
Sara Laurencin
JRJ. Rue
J. Rue
FVF. Vaysse
F. Vaysse
ARA. Roméas
A. Roméas
GBG. Brunel
G. Brunel

23 August 2018 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
Jean-Noel VergnesJean-Noel Vergnes
Jean-Noel Vergnes
Thibault CanceillThibault Canceill
Thibault Canceill
AVAlexia Vinel
Alexia Vinel
SLSara Laurencin
Sara Laurencin
FMFrançoise Maupas‐Schwalm
Françoise Maupas‐Schwalm
TGthe DIAPERIO Group
the DIAPERIO Group